4//SEC Filing
FLATLEY JAY T 4
Accession 0001645842-22-000149
CIK 0001645842other
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 8:17 PM ET
Size
394.9 KB
Accession
0001645842-22-000149
Insider Transaction Report
Form 4
FLATLEY JAY T
DirectorChairman and Acting CEO
Transactions
- Disposition to Issuer
Common Stock
2022-10-19−144,789→ 0 total - Disposition to Issuer
Stock Options
2022-10-19−189,125→ 0 totalExercise: $8.52Exp: 2029-09-17→ Common Stock (189,125 underlying) - Disposition to Issuer
Stock Options
2022-10-19−1,520,000→ 0 totalExercise: $12.33Exp: 2031-08-06→ Common Stock (1,520,000 underlying)
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 24, 2022 (the "Merger Agreement"), by and among Ginkgo Bioworks Holdings, Inc. ("Ginkgo"), Pepper Merger Subsidiary Inc. and the Issuer, each share of the Issuer's common stock was cancelled and converted into a right to receive 0.9179 of a share of Class A common stock of Ginkgo (the "Merger Consideration"), together with cash in lieu of any fractional shares of Class A common stock of Ginkgo.
- [F2]Immediately prior to the effective time of the merger (the "Effective Time"), all outstanding Issuer stock options vested in full pursuant to the terms of the agreements governing such stock options. Pursuant to the Merger Agreement, at the Effective Time, each Issuer stock option with an exercise price per share equal to or greater than the Merger Consideration Value (as defined in the Merger Agreement) was cancelled for no consideration.
Issuer
Zymergen Inc.
CIK 0001645842
Entity typeother
Related Parties
1- filerCIK 0001189130
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 8:17 PM ET
- Size
- 394.9 KB